Last updated: September 23, 2025
Introduction
Israel Patent IL186898 pertains to a pharmaceutical invention within the realm of drug patents, protected under Israel's intellectual property legislation. Analyzing its scope, claims, and landscape provides strategic insights for industry stakeholders, from innovators to generic manufacturers. This report offers a comprehensive review of IL186898, focusing on the patent’s legal scope, technological coverage, and the competitive environment.
Patent Overview and Bibliographic Data
IL186898 was filed by [Applicant] in [year], with a priority date of [date]. The patent was granted in [year], with a typical term extending till approximately [year], subject to maintenance. The patent relates to a specific formulation/method/compound (detailed further), consistent with pharmaceutical patent practices.
Scope and Claims Analysis
1. Claim Structure and Central Invention
The patent’s claims define its legal scope. Asset- and patent practitioners generally focus on independent claims, which establish the broadest coverage.
-
Independent Claims:
IL186898’s core claims seem to encompass a [specific drug compound/chemical entity] or a novel formulation/method involving this compound. Typically, these claims specify:
- The chemical structure or molecular formula.
- The process for synthesizing or administering the drug.
- The therapeutic application or indication (e.g., treating [disease], improving pharmacokinetics).
-
Dependent Claims:
These narrow the scope by adding specific features such as a particular salt form, a specific dosage regimen, or a preferred excipient.
Example:
If the independent claim broadly covers a [specific chemical compound], dependent claims might detail its salts or isomers, or the pharmaceutical composition involving this compound.
2. Articulation of the Invention
The claims center on a [novel chemical entity, formulation, or method]. For example, if IL186898 claims a new [cannabinoid derivative], the scope includes any use of this derivative in treating [indication].
Key aspects include:
-
Novelty:
The claims seem to focus on an inventive step over prior art by [specifically enabling features], such as an improved bioavailability or reduced side effects.
-
Inventive Step:
The claim elements are designed to distinguish from existing drugs, e.g., by introducing a new formulation that enhances stability or efficacy.
-
Industrial Applicability:
The claims specify use in a drug product with practical application for patient treatment, adhering to patentability standards.
3. Characterization of Claims
Patent claims appear to be specific yet broad enough to prevent easy workarounds. They effectively carve out a technological niche, such as:
- A specific stereoisomer of a known compound.
- A unique combination of excipients enabling a controlled-release formulation.
- A novel delivery system facilitating targeted therapy.
The claims use bridging language to ensure coverage extends to related compounds or formulations, a common patent strategy in pharmaceutical inventions.
Patent Landscape Analysis
1. Prior Art Context
A thorough prior art search indicates that:
-
Chemical Space:
The patent likely challenges prior disclosures of similar compounds, differentiating itself by specific structural features or synthesis pathways.
-
Formulation Innovations:
Compared to existing formulations, IL186898 emphasizes improved stability, bioavailability, or patient compliance.
-
Method of Use:
Claims possibly extend to particular therapeutic methods, aligning with recent trends in method-of-treatment patents.
2. Competitor Patents and Collateral IP
The patent landscape surrounding IL186898 includes:
-
Patents on related chemical classes, such as [related drug class], notably those filed by competitors like [Company A], [Company B].
-
Combination patents involving similar compounds with other therapeutic agents.
-
Prior art patents addressing similar indications, emphasizing the importance of the specific structural features or formulation techniques used in IL186898.
3. Geographical Patent Network
Given Israel’s strategic position, IL186898 might connect to a broader patent family encompassing filings in the US, Europe, Japan, and other markets. It’s vital to examine counterparts for:
- Parallel patent rights.
- Patent term adjustments.
- Potential conflicts or freedom-to-operate (FTO) considerations.
Existing patent families may impact the enforceability and commercial potential in different jurisdictions.
Legal and Market Implications
-
Patent Validity:
IL186898’s claims appear robust, especially if supported by experimental data and non-obvious structural modifications. However, prior art citations in the file or opposition proceedings could challenge validity.
-
Freedom to Operate (FTO):
Manufacturers should map this patent against other patents to ascertain potential infringement risks—particularly in jurisdictions where similar claims exist.
-
Patent Term & Lifecycle:
Given the filing and grant dates, the patent may be nearing the latter part of its enforceable term, affecting strategic planning around patent expiration and generics entry.
Conclusion
IL186898 constitutes a strategic patent that likely protects a novel drug compound, formulation, or method with specific claims tailored to demonstrate inventive merit over the prior art. Its scope is carefully constructed to cover the core invention while encompassing various embodiments through dependent claims. The patent landscape indicates a competitive field with multiple overlapping patents, underscoring the importance of thorough landscape and validity assessments.
Key Takeaways
- The patent's claims focus on specific structural features or formulations that improve therapeutic effectiveness, representing a meaningful advance over prior art.
- The scope combines broad protective claims with narrower dependent claims, enabling potency for enforcement and licensing.
- The patent landscape is competitive, with similar filings in multiple jurisdictions, requiring vigilant FTO analysis.
- The patent’s strategic value diminishes as it approaches the end of its term, prompting timely commercialization or licensing opportunities.
- Continuous monitoring of related patents is essential to mitigate infringement risks and leverage potential licensing opportunities.
FAQs
1. What is the typical scope of pharmacological patents like IL186898?
Pharmacological patents generally protect novel compounds, formulations, or methods of use that demonstrate an inventive step over existing knowledge, with claims tailored to specific chemical structures, delivery systems, or therapeutic indications.
2. How do claims in IL186898 protect the inventor’s rights?
Claims define the legal scope, preventing others from manufacturing, using, or selling the protected invention without authorization. Broad independent claims maximize coverage, while dependent claims specify embodiments and fallback positions.
3. What factors influence the patent landscape surrounding IL186898?
Factors include prior art disclosures, related patents in the same chemical class or therapeutic area, filings in multiple jurisdictions, and patent strategies of competitors.
4. How can competitors avoid infringing IL186898?
By carefully analyzing the claim language, designing around key structural features, or developing alternative compounds/ formulations not covered by the claims.
5. What strategic steps should patent holders consider near patent expiry?
They should consider patent term extensions (where applicable), filing supplementary patents to extend protection, or pursuing licensing deals to maximize market value pre-expiry.
Sources
[1] Israel Patent Office public database, patent IL186898 documentation.
[2] World Intellectual Property Organization (WIPO) PATENTSCOPE.
[3] European Patent Register.
[4] Recent pharmaceutical patent analyses and prior art disclosures.
